FDA Inspection 1223634 — Cooper Institute for Advanced Reproductive Medicine

Cooper Institute for Advanced Reproductive Medicine — FEI 3011006339

The FDA completed an inspection of Cooper Institute for Advanced Reproductive Medicine on November 16, 2023 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 16, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)